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The Forkhead Transcription Factor Foxo1
Regulates Adipocyte Differentiation
growth arrest associated with terminal differentiation.
These processes are accompanied by characteristic
changes in gene expression.
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1Naomi Berrie Diabetes Center Insulin and insulin-like growth factor-1 promote differ-
entiation of preadipocytes in vitro (Rubin et al., 1977).Department of Medicine
College of Physicians and Surgeons 3T3-L1 cells with partial inactivation of Insulin Receptor
(Insr) display impaired adipocyte differentiation (Acciliof Columbia University
New York, New York 10032 and Taylor, 1991), and Insr knockout mice have marked
adipose tissue hypotrophy (Cinti et al., 1998). Moreover,2 Ludwig Institute for Cancer Research
University of California, San Diego embryonic fibroblasts (EF) with combined ablation of
the insulin receptor substrates Irs1 and Irs2 fail to differ-La Jolla, California 92093
entiate into adipocytes (Miki et al., 2001). Adipocyte
differentiation is associated with a transient increase of
PI 3-kinase activity (Sakaue et al., 1998) and can beSummary
induced by overexpression of a constitutively active
form of Akt, one of the PI 3-kinase-activated kinasesAn outstanding question in adipocyte biology is how
(Kohn et al., 1996). These data are consistent with a rolehormonal cues are relayed to the nucleus to activate
of insulin-stimulated PI 3-kinase signaling in adipo-the transcriptional program that promotes adipogen-
genesis. However, the mechanism by which the PIesis. The forkhead transcription factor Foxo1 is regu-
3-kinase → Akt signal is relayed to the nucleus to acti-lated by insulin via Akt-dependent phosphorylation
vate adipocyte differentiation is unknown.and nuclear exclusion. We show that Foxo1 is induced
Akt phosphorylates the Foxo transcription factorsin the early stages of adipocyte differentiation but that
(Kaestner et al., 2000) and inhibits their transcriptionalits activation is delayed until the end of the clonal
activity (Datta et al., 1999; Kops and Burgering, 1999).expansion phase. Constitutively active Foxo1 prevents
Foxo1 is the most abundant Foxo isoform in severalthe differentiation of preadipocytes, while dominant-
insulin-responsive tissues, such as liver, adipose, andnegative Foxo1 restores adipocyte differentiation of
pancreatic  cells. We have shown that Foxo1 regulatesfibroblasts from insulin receptor-deficient mice. Fur-
glucose-6-phosphatase (Nakae et al., 2001) and Pdx1ther, Foxo1 haploinsufficiency protects from diet-
expression (Kitamura et al., 2002) and is involved ininduced diabetes in mice. We propose that Foxo1 plays
insulin inhibition of hepatic glucose production andan important role in the integration of hormone-acti-
stimulation of  cell proliferation (Nakae et al., 2002). Invated signaling pathways with the complex transcrip-
the present study, we investigated the role of Foxo1 intional cascade that promotes adipocyte differenti-
adipose tissue. Our data indicate that Foxo1 plays anation.
important role in coupling insulin signaling to adipocyte
differentiation.Introduction
White adipose tissue plays an important metabolic role
Results and Discussionby storing triacylglycerol in periods of energy excess
and releasing free fatty acids and glycerol during energy
Foxo Isoform Expression duringdeprivation (Spiegelman and Flier, 2001). Furthermore,
3T3-F442A Differentiationadipocytes secrete a number of hormones, collectively
In vitro differentiation of committed preadipocytes fol-termed adipokines, that regulate metabolic homeostasis
lows a well-characterized sequence: upon reaching(Ahima and Flier, 2000). In rodents, brown adipose tissue
confluence (day 0), cells undergo limited clonal expan-has been implicated in thermogenesis. Increased fat
sion (days 1–2), postmitotic growth arrest (days 3–4),deposition results in obesity, which, in turn, predisposes
and terminal differentiation (days 4–10).to type 2 diabetes, cardiovascular diseases, hyperten-
Real-time RT-PCR analysis (Figure 1A) indicates thatsion, sleep apnea, and musculoskeletal disorders (Spie-
Foxo1 is the most abundant Foxo isoform in murinegelman and Flier, 2001).
white and brown adipose tissue, with levels 50% andThe process of adipocyte differentiation has been ex-
70% of those detected in liver (Nakae et al., 2002). Intensively characterized in cultures of clonal cell lines of
3T3-F442A preadipocytes, mRNA levels of the three iso-preadipocytes, such as mouse 3T3-L1 and 3T3-F442A
forms are comparably low (Figure 1B). However, during(Gregoire et al., 1998; Rosen et al., 2000). In vitro adipo-
differentiation, Foxo1 expression increases up to 6-foldgenesis requires a sequence of events, including growth
over basal levels, peaking at day 4, to then partiallyarrest of proliferating preadipocytes, coordinated reen-
decline, while Foxo3 expression does not change signifi-try into the cell cycle with limited clonal expansion, and
cantly. Foxo4 expression nearly doubles by the end of
differentiation (Figures 1B and 1C). These data indicate*Correspondence: da230@columbia.edu
that Foxo1 shows a unique expression pattern among3 Present address: Department of Pediatrics, Asahikawa Medical
College, Asahikawa 078-8510, Japan. Foxos during differentiation of 3T3-F442A cells.
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adipocyte differentiation, we measured immunoreactiv-
ity with a phosphospecific antibody against Ser253, the
main Akt phosphorylation site (Nakae et al., 2000). To
this end, we transduced confluent 3T3-F442A cells with
adenovirus encoding HA-tagged Foxo1. Phosphoryla-
tion of Ser253 was detectable at day 1, peaked at day 2,
and returned to basal levels at day 3. Western blotting
with anti-HA antibody shows that Foxo1 expression was
constant during the experiment (Figure 2A). These data
indicate that phosphorylation of Foxo1 is regulated in a
stage-dependent manner.
We next investigated the subcellular distribution of
Foxo1 during adipocyte differentiation by immunocyto-
chemistry. Foxo1 was undetectable in preadipocytes
(Figure 2B, day 0). At day 2, it was largely detected in
a cytoplasmic localization. At day 4, it could be detected
in a typical nuclear localization pattern, and, at day 10,
it localized throughout the cell. Thus, these experiments
indicate a correlation between phosphorylation and
subcellular localization.
Here is a summary of these findings. Foxo1 expression
is activated in preadipocytes coincidentally with growth
arrest and peaks at the onset of terminal differentiation.
However, during the clonal expansion phase, Foxo1 is
inactive because it is phosphorylated. Activation occurs
before the onset of terminal differentiation, when Foxo1
becomes dephosphorylated and localizes to the nu-
cleus. Interestingly, this is also the time when mRNA
levels reach their maximal levels. These data suggest a
requirement for Foxo1 during the transition from clonal
expansion to terminal differentiation of preadipocytes,
and they are consistent with Foxo1’s role to induce cell
cycle inhibitors, such as p27 (Medema et al., 2000) and
the retinoblastoma-like protein p130 (Kops et al., 2002).
A Gain-of-Function Foxo1 Mutant Inhibits
Adipocyte Differentiation
To investigate the role of Foxo1 in adipocyte differentia-
tion, we transduced 3T3-F442A cells with four different
adenoviral vectors encoding wild-type, constitutively
active (ADA), or dominant-negative (256) Foxo1, as well
as LacZ as a control for adenoviral toxicity. The constitu-
Figure 1. Expression of Foxo Isoforms in Adipose Tissue and during tively active Foxo1 carries mutations of the three main
3T3-F442A Adipocyte Differentiation phosphorylation sites; as a result, it cannot be excluded
(A) Relative mRNA abundance of Foxo1, 3, and 4 in liver, white from the nucleus in response to insulin (Nakae et al.,
adipose tissue (WAT), and brown adipose tissue (BAT). We analyzed
2001). The dominant-negative Foxo1 contains the fork-2-month-old mice (n  3). A bar indicates the mean SEM. An
head DNA binding domain but lacks the transactivationasterisk indicates a significant difference between Foxo1 and other
domain. As a result, it is transcriptionally inactive andFoxo isoforms (p  0.001 by ANOVA).
(B) Representative experiment showing mRNA levels of Foxo iso- prevents DNA binding of endogenous Foxo1 (Nakae et
forms in 3T3-F442A cells during differentiation. mRNA was hybrid- al., 2001). We carried out adenoviral transduction at the
ized sequentially with probes encoding Foxo1 (top panel), Foxo3 time of induction of differentiation (48 hr postconflu-
(second panel from the top), and Foxo4 (third panel from the top)
ence). Expression of wild-type Foxo1 and LacZ had noand normalized with -actin (bottom panel).
effect on adipocyte differentiation (data not shown). Ex-(C) Summary of time-course analyses of Foxo isoform expression
pression of the Foxo1-ADA and Foxo1-256 mutantsfrom several independent differentiation experiments. An asterisk
indicates a significant difference at each time point between Foxo1 was detected within one day of transduction and per-
and other Foxo isoforms (p  0.001 by ANOVA). sisted for up to 7 days. The ADA mutant showed a peak
of expression after 2 days, which was not observed with
the 256 mutant (Figure 3A).
Expression of the Foxo1-ADA mutant resulted in aFoxo1 Phosphorylation and Subcellular Localization
during Adipocyte Differentiation dose-dependent inhibition of adipocyte differentiation,
as assessed by oil red O staining (Figure 3B) and by theFoxo1 is regulated via phosphorylation by Akt and other
PI-dependent kinases (Kops and Burgering, 1999). To reduced expression of Ppar and Glut4 7 days postin-
duction (Figure 3C). Transduction of 3T3-F442A cellsstudy the regulation of Foxo1 phosphorylation during
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Figure 2. Phosphorylation and Subcellular
Localization of Foxo1 in Differentiating Adi-
pocytes
(A) Foxo1 phosphorylation in 3T3-F442A cells
is regulated in a stage-dependent manner
during differentiation. We transduced 3T3-
F442A cells with HA-tagged wild-type Foxo1
one day prior to induction of differentiation.
We collected cells at various time points dur-
ing differentiation and performed sequential
Western blotting with anti-pSer253 (top panel)
and anti-HA antibodies (bottom panel). A rep-
resentative experiment is shown.
(B) Detection of Foxo1 subcellular localiza-
tion by immunocytochemistry. Cells were
plated on chamber slides and fixed at differ-
ent points during the differentiation process.
We used anti-Foxo1 antiserum to detect the
endogenous Foxo1 using immunofluores-
cence.
with the Foxo1-ADA mutant after clonal expansion did In summary, inhibition of adipocyte differentiation by
not affect adipogenesis. Likewise, transduction of fully the Foxo1-ADA mutant is associated with induction of
differentiated cells did not result in dedifferentiation. the cell cycle inhibitors p21, p27, and pRb and the C/EBP
These data indicate that ectopic nuclear expression of dimerization partner Chop10 (Figure 3D). These findings
Foxo1 prior to terminal differentiation arrests adipose are consistent with the possibility that Foxo1 inhibits
conversion of 3T3-F442A cells. adipocyte differentiation via a complex mechanism. On
To identify Foxo1 target genes, we performed time- the one hand, Foxo1 appears to induce an early growth
course analyses of mRNA expression in cells expressing arrest, which could potentially prevent clonal expansion
the ADA mutant (Figure 3C). Expression of C/EBP and of committed preadipocytes; on the other hand, Foxo1
C/EBP was prematurely induced and returned to basal may directly inhibit C/EBP-dependent terminal differen-
levels by day 7. Interestingly, these two isoforms have tiation via increased Chop10 expression.
been shown to induce Ppar expression (Wu et al., 1999)
but, in Foxo1-ADA-transduced cells, failed to do so. A
potential explanation for this finding emerged from the Ectopic Expression of Dominant-Negative Foxo1
analysis of Chop10/Gadd153 expression. Chop10 is a Restores Adipocyte Differentiation of EF
member of the C/EBP family that lacks a DNA binding Lacking Insulin Receptors
domain and is thought to inhibit C/EBP function via Since a constitutively active Foxo1 mutant inhibits adi-
dimerization with the various isoforms (Batchvarova et pocyte differentiation, we asked whether a dominant-
al., 1995; Tang and Lane, 2000). In untransduced cells, negative mutant enhances adipogenesis. In 3T3-F442A
Chop10 expression was characteristically inhibited in cells, transduction with the256 mutant results in earlier
the early phases of adipocyte differentiation and in-
induction of adipocyte-specific genes and adipose con-
duced during terminal differentiation. The expression
version. Next, we asked whether the Foxo1-256 mutant
pattern of Chop10 in cells transduced with the Foxo1-
would be able to restore adipogenesis in EF from Insr/ADA mutant was reversed, with an early induction fol-
mice. We have previously shown that Insr/ mice havelowed by a return to basal levels at the end of the differ-
hypotrophic adipose tissue (Cinti et al., 1998).entiation phase.
Similar to EF from Irs1/Irs2 double knockout mice (MikiExpression of the cell cycle control genes pRb, p21,
et al., 2001), Insr/ EF failed to convert to adipocytes inand p27 was strongly induced at day 2 and returned to
the presence of insulin/dexamethasone/IBMX (Figurenormal thereafter. This induction coincided with peak
4A) or Ppar ligand (data not shown). In contrast, follow-levels of Foxo1-ADA expression. Expression of Ppar,
ing transduction with the 256 mutant, Insr/ EF par-Glut4, Acrp30 (Figure 3D), and C/EBP	 (data not shown)
tially differentiated into mature adipocytes in the pres-was abrogated, consistent with the lack of adipose dif-
ence of hormonal induction (Figure 4A) or Ppar ligandferentiation. The data are summarized in Figure 3D.
(data not shown). Furthermore, Northern blotting analy-In contrast to the Foxo1-ADA mutant, transduction
sis showed restored expression of adipocyte-specificwith Foxo1-256 was associated with earlier induction
genes in 256-transduced, compared with nontrans-of adipocyte differentiation (data not shown). This
duced, Insr/ EF, while expression of cell cycle controlchange was paralleled by an earlier induction of Ppar,
and C/EBP genes had not been affected (Figure 4B).Glut4, and Acrp30 expression, while expression of
These data indicate that the 256 mutant can partiallyC/EBP, C/EBP, Chop10, p27, pRb, and p21 was un-
changed (Figures 3C and 3D). restore adipocyte differentiation.
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Figure 3. Inhibition of Adipocyte Differentiation by the Constitutively Active Mutant Foxo1-ADA
(A) Time-course analysis of adenoviral protein expression. Cells were transduced at day 0, and extracts were prepared at different time points.
The Foxo1-ADA mutant is shown in the upper panel, and Foxo1-256 mutant is shown in the lower panel. Equal amounts of protein extract
were applied to each lane. The lower band observed at day 4 in 256-transduced cells is a dephosphorylated form of Foxo1.
(B) Effect of the constitutively active mutant Foxo1-ADA on adipocyte differentiation. The mutant protein was expressed with different moi of
crude adenoviral preparations. We carried out transduction on the day of induction (i.e., 48 hr postconfluence). After removal of the adenoviral
extract, cells underwent the regular differentiation protocol. The extent of adipocyte differentiation was determined by oil red O staining.
(C) Time-course analysis of gene expression in nontransduced 3T3-F442A cells (left panels) or after transduction with Foxo1-ADA (middle
panels) or Foxo1-256 (right panels).
(D) Quantification of relative mRNA abundance in 3T3-F442A cells during differentiation. Expression of each mRNA was quantified by scanning
densitometry of the autoradiogram and normalized with -actin.
Mechanisms of Foxo1 Regulation of Adipogenesis increased in Foxo1-transduced cells, the increase in p27
expression was not paralleled by changes in proteinThe ability of Foxo1 to prevent adipose differentiation
is associated with increased expression of cell cycle levels (Figure 4C), and p27 gradually declined during
differentiation. Moreover, cells transduced with the256inhibitors and of the C/EBP modulator Chop10. We
sought to identify bona fide Foxo1 targets among these mutant showed persistent p27 expression, suggesting
that alterations of p27 levels are not responsible forgenes. Although others have shown (Medema et al.,
2000), and our present data confirm, that p27 expression the inhibitory effect of the constitutively active Foxo1
Foxo1 in Adipocyte Differentiation
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Figure 4. The Dominant-Negative Foxo1-256 Restores Adipocyte Differentiation in EF from Insr/ Mice
(A) Oil red O staining in nontransduced cells (left panel) or in 256-transduced (right panel) cells. Cells were grown to confluence and incubated
with insulin/dexamethasone/IBMX to induce differentiation. They were stained with oil red O to assess triglyceride accumulation at day 14
postinduction.
(B) Time-course analysis of gene expression in Insr/ EF in the absence () and presence (
) of the Foxo1-256 mutant.
(C) Analysis of p27 protein expression by immunoblotting with anti-p27 antibody of extracts from nontransduced cells (upper panel) or
cells transduced with Foxo1-ADA (middle panel) and Foxo1-256 (lower panel). Cells were harvested at the indicated time points during
differentiation.
mutant. Moreover, Foxo1 has been shown to induce cell contrast, p21 reporter gene expression induced by the
constitutively active Foxo1-ADA mutant was paradoxi-cycle arrest of p27/ fibroblast, suggesting that p27
is not required for the effects of Foxo1 on cell cycle cally stimulated in the presence of insulin. The dominant-
negative mutant Foxo1-256 suppressed p21-mediatedprogression (Kops et al., 2002).
Since p21 has been implicated in the termination of reporter gene expression (Figure 5A). Expression levels
of wild-type and Foxo1-ADA were similar (Figure 5B).clonal expansion (Morrison and Farmer, 1999), we next
investigated its regulation by Foxo1. Inspection of the To investigate whether Foxo1 can regulate expression
of the endogenous p21, we transduced LLC kidney epi-mouse p21 promoter region revealed several potential
Foxo1 binding sites (AAAC/TA) in a tandem repeat ar- thelial cells and SV40-transformed hepatocytes with the
256 or ADA mutants and measured p21 mRNA. Therangement between nucleotides (nt) –1337 and –1395
and nt –2596 and –2638. In cotransfection experiments, ADA mutant increased p21 expression by 65% com-
pared with nontransduced LLC cells. The rise in p21wild-type Foxo1 increased luciferase activity mediated
through the p21 promoter by 4-fold (p  0.001 by mRNA levels was suppressed in a dose-dependent
manner by the 256 mutant (Figure 5C). In culturedANOVA) (Figure 5A). Addition of insulin resulted in an
25% inhibition of Foxo1-dependent transcription. In hepatocytes, the Foxo1-ADA mutant increased p21
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Figure 5. Foxo1 Regulates the p21 Promoter in an Insulin-Inhibitable Manner
(A) Expression of a p21-luciferase reporter gene in SV40-transformed hepatocytes. Cells were transiently cotransfected with wild-type or
mutant Foxo1 (ADA and 256) and a p21-luciferase reporter construct. Twenty-four hours after transfection, some cells were treated with
insulin (full bars). We used -galactosidase to normalize luciferase activity for transfection efficiency. A bar represents the mean SEM of
three experiments. An asterisk on the empty bars indicates a significant difference between mock-transfected (empty vector) and Foxo1-
transfected cells (p  0.001 by ANOVA). An asterisk on the full bars indicates a significant difference between insulin-treated cells and basal
luciferase activity in the same experiment (p  0.05 by ANOVA).
(B) Expression of cMyc-tagged Foxo1 wild-type and ADA mutant was determined by immunoblotting with anti-Foxo1 antiserum in total cell
extracts after transient transfection.
(C) Effect of constitutively active and dominant-negative Foxo1 mutants on endogenous p21 mRNA in kidney epithelial LLC cells (left panel)
and SV40-transformed hepatocytes (right panel). LLC cells were transduced with the 256 mutant at increasing moi, in the absence or presence
of a fixed amount of Foxo1-ADA. SV40-transformed hepatocytes were transduced with Foxo1-ADA and treated with insulin.
(D) Gel shift assays. Oligonucleotide probes corresponding to the forkhead binding site at nt 1369–1395 of the p21 promoter were incubated
with nuclear extracts in the absence or presence of increasing amounts of unlabeled control or mutant oligo (left panel). In the right panel,
anti-cMyc antiserum was added to the reaction mix containing the wild-type or mutant probe. The position of the gel-retarded complex is
indicated as A, and that of the super-shifted complex is indicated as B.
(E) Chromatin immunoprecipitation assays. We incubated crosslinked chromatin from cells at the indicated differentiation stages with anti-
Foxo1 antiserum (lane 2) or control serum (lane 3). We analyzed the immunoprecipitated DNA with PCR primers to amplify the p21 promoter
sequence. As controls, we show PCR reactions with total input chromatin (lane 1) and without added DNA (lane 4).
(F) Analysis of p21 protein expression by immunoblotting with anti-p21 antibody of extracts from nontransduced cells (upper panel) or cells
transduced with Foxo1-ADA (lower panel). Cells were harvested at the indicated time points during differentiation.
expression 4-fold compared with nontransduced hepa- We next analyzed Foxo1’s ability to bind the p21 pro-
moter in gel shift and chromatin immunoprecipitationtocytes. This induction was unaffected by insulin treat-
ment (Figure 5C). These data indicate that Foxo1 regu- (ChIP) assays. Incubation of nuclear extracts from cells
expressing cMyc-tagged Foxo1 with a probe encodinglates p21 transcription.
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the forkhead binding site between nt –1369 and –1395 extent as wild-type littermates (Figure 6A). However,
unlike wild-type littermates, some of which developedin the p21 promoter yielded a gel-retarded complex that
diabetes (defined as whole blood glucose values greatercould be competed by excess cold probe, but not by
than the mean plus 2 SD on two separate occasions),a mutant probe. Complex A was super shifted by the
all Foxo1
/ mice remained euglycemic (Figures 6B andaddition of anti-cMyc antiserum to yield complex B (Fig-
6C). Moreover, wild-type mice rapidly developed hyper-ure 5D). We detected no binding to the mutant probe
insulinemia, consistent with insulin resistance. In con-and weak binding to the second forkhead site (nt –1337
trast, Foxo1
/ mice developed hyperinsulinemia onlyto –1367; data not shown). These data indicate that
at the end of the treatment period and to a significantlyFoxo1 can bind to the p21 promoter and regulate its
lower extent than wild-type controls (Figure 6D).expression in an insulin-inhibitable manner.
A metabolic characterization of high-fat-fed mice con-ChIP assays provided evidence that the interaction
firmed the protective effect of Foxo1 haploinsufficiencybetween Foxo1 and the p21 promoter occurs in vivo in
against diet-induced insulin resistance and diabetes.a stage-specific fashion. In crosslinked chromatin iso-
Thus, wild-type mice showed abnormal glucose (Figurelated from cells during clonal expansion and immuno-
6E) and insulin tolerance (Figure 6F) at the end of theprecipitated with anti-Foxo1 antiserum, we detected an
experiment. Foxo1
/ mice showed a mild, nonsignifi-amplified product corresponding to the p21 promoter,
cant deterioration of glucose tolerance (Figure 6E) andwith only trace amounts of nonspecific binding to control
no change in insulin tolerance (Figure 6F).
serum (Figure 5E). The intensity of the amplified signal
We next analyzed size, cellular composition, and gene
declined by80% in cells undergoing terminal differen-
expression in epididymal fat pads. The weight of epidid-
tiation, consistent with a decrease in Foxo1 binding, as ymal fat pads nearly doubled in both genotypes after
might have been expected on the basis of the nuclear 15 weeks of high-fat diet (Figure 7A). The increase in
exclusion of Foxo1 at this stage. size was associated with increased cell size in wild-type
Changes in p21 protein levels, measured by Western mice. In contrast, cell size was unchanged in Foxo1
/
blotting with anti-p21 antiserum in cells transduced with mice (Figure 7B). Fat cell density decreased in high-fat-
ADA or D256 mutants, mirrored the changes in mRNA fed wild-type mice but remained constant in Foxo1
/
levels. Thus, in untransduced 3T3-F422A cells, p21 lev- mice (Figure 7C), suggesting that Foxo1 haploinsuffi-
els declined during clonal expansion (Figure 5F, com- ciency prevents adipocyte hypertrophy in response to
pare lanes 1 and 2). In contrast, p21 levels increased in high-fat feeding. Interestingly, Foxo1 haploinsufficiency
ADA-expressing cells. had a similar effect to reduce adipocyte size in insulin-
The Chop10 promoter also contains potential fork- resistant Insr
/ mice (data not shown).
head bindings sites. However, in transient transfection We analyzed expression of several genes involved in
experiments, Foxo1 failed to affect Chop10 promoter adipocyte metabolism using real-time RT-PCR. In wild-
activity, suggesting that the changes in Chop10 expres- type mice, expression of Ppar, Glut4, Leptin, Acrp30,
sion are not a direct result of Foxo1 binding to its pro- and Srebp-1c decreased75% following a high-fat diet.
moter (data not shown). No changes were observed in the expression of Tnf	
and Resistin (Figure 7D, empty circles). In Foxo1
/ mice,In summary, from this analysis, we identified the cell
we observed a modest decrease of Ppar, whereascycle inhibitor p21 as a bona fide Foxo1 target with a
Glut4 levels rose slightly. Leptin, Acrp30, and Srebp-1cpotential role in Foxo1 control of adipogenesis. The role
levels were lower in Foxo1
/ mice on normal chow thanof p27 in Foxo1-dependent adipogenesis remains un-
in wild-type mice and did not change following the high-clear. Recently, it has been suggested that overexpres-
fat diet. Moreover, we observed a decrease in Tnf	 andsion of Wnt may also block adipogenesis by preventing
Resistin levels (Figure 7D, filled circles).the downregulation of p27 that is associated with clonal
These data demonstrate a protective effect of Foxo1expansion (Ross et al., 2002). However, in view of the
haploinsufficiency against the deterioration of insulinfact that cells expressing the dominant-negative Foxo1-
sensitivity associated with diet-induced obesity. In addi-256 undergo robust differentiation and fail to downreg-
tion to preserved fuel metabolism, Foxo1
/ mice showedulate p27 expression, it appears that p27 is not the
none of the changes in gene expression that would predis-mediator of Foxo1’s effect on adipogenesis.
pose to insulin resistance in the fat cell. Notably, Ppar
expression did not change, and expression of two adipo-
kines— Tnf	 and Resistin—paradoxically decreased in
Foxo1 Haploinsufficiency Prevents Insulin high-fat-fed Foxo1
/ mice.
Resistance and Diabetes Induced
by a High-Fat Diet Conclusions
To investigate the role of Foxo1 in adipose tissue in vivo, The data presented shed light onto two unresolved is-
we analyzed the effects of Foxo1 haploinsufficiency in sues in adipocyte biology: the mechanism by which hor-
a model of diet-induced diabetes. We have previously monal signaling activates transcriptional responses and
shown that Foxo1 haploinsufficiency restores insulin the complex relationship between cell cycle control and
sensitivity in insulin-resistant mice (Insr
/) by a complex induction of adipogenesis.
mechanism involving decreased hepatic glucose pro- There are some precedents for regulation of adipo-
duction, increased pancreatic  cell compensation, and genesis through phosphorylation of transcription fac-
increased expression of insulin-sensitizing genes in adi- tors. For example, activation of MAP kinase has been
pose tissue (Nakae et al., 2002). When Foxo1
/ mice shown to inhibit adipogenesis through Ppar phosphor-
ylation (Hu et al., 1996), while the stress-activated kinasewere fed a high-fat diet, they gained weight to the same
Developmental Cell
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Figure 6. Foxo Haploinsufficiency Protects
against Diet-Induced Diabetes
(A) Foxo1
/ mice and wild-type littermate
controls were fed either regular, high-carbo-
hydrate (HC) chow or a high-fat diet (HF) start-
ing at weaning for a 15 week period. Body
weights were measured at 3 week intervals
(n  8 wt and 12 Foxo1
/ on the control HC
diet and 17 wt and 18 Foxo1
/ on the HF
diet).
(B and C) Glucose levels in the fed state. The
mean values SEM are indicated in (B), and
individual values are shown in (C). Mice with
glucose values greater than the mean plus 2
SD on two or more occasions were consid-
ered diabetic.
(D) Insulin levels were measured in random-
fed animals at the indicated time points dur-
ing the 15 week experiment.
(E and F) Metabolic characterization of high-
fat-fed mice. Intraperitoneal glucose (E) and
insulin tolerance (F) tests were performed as
described previously (n  10 for each geno-
type and each experimental condition). An
asterisk indicates that p  0.01 by ANOVA.
p38 inhibits adipogenesis via increased Chop10 phos- phosphorylation appears to be required during the
clonal expansion phase, and our data show that unre-phorylation (Wang and Ron, 1996). However, it is not
known how insulin-induced protein phosphorylation is strained Foxo1 activity prevents terminal differentiation.
These observations also appear to support the viewlinked to the activation of adipogenesis. The present
data provide a direct link between insulin signaling that clonal expansion is a requirement for terminal differ-
entiation. The antiadipogenic effect of the Foxo1-ADAthrough Irs → PI 3-kinase → Akt and adipogenesis
through Foxo1 phosphorylation. Inhibition of Foxo1 via mutant is associated with marked induction of several
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cell cycle inhibitors, including p21, pRb, and p27. The
regulation of p21 by Foxo1 represents a potential mech-
anism to explain the observed effects. The increase in
p21 expression induced by Foxo1-ADA could prevent
adipocyte differentiation by inhibiting clonal expansion.
The notion that p21 is regulated by Foxo1 changes our
understanding of this key step in adipocyte differentia-
tion. In fact, it has been shown that p21 expression can
be regulated in a Ppar ligand-dependent manner in cells
expressing Ppar (Morrison and Farmer, 1999). These
data, along with the demonstrated ability of both C/EBPs
and Ppar to induce growth arrest of preadipocytes,
have generally been interpreted as supporting the view
that Ppar is upstream of p21 in the process of adipocyte
differentiation (Spiegelman and Flier, 2001). However,
in cells expressing Foxo1-ADA, increased p21 expres-
sion is dissociated from Ppar induction, raising the
possibility that control of p21 expression is exerted up-
stream of Ppar by Foxo1. The complex relationship
among Foxo1, p21, C/EBP, and Ppar deserves further
investigation.
Interestingly, we found that Foxo1 also binds to fork-
head sites of the Rb promoter in gel shift assays (data
not shown), suggesting that Rb is also a Foxo1 target.
The role of Rb in adipocyte differentiation and its interac-
tion with the C/EBP and Ppar transcription factors is
underscored by the observation that Rb/ EF fail to
differentiate into adipocytes (Chen et al., 1996) but can
be rescued by Ppar ligands (Hansen et al., 1999). More-
over, the pRb target E2F has been shown to regulate
clonal expansion of preadipocytes (Fajas et al., 2002).
Thus, it is possible that Foxo1 controls adipocyte differ-
entiation through interactions with several genes in-
volved in progression through the cell cycle. Interest-
ingly, a similar phenotype has been observed in
preadipocytes overexpressing Wnt (Ross et al., 2002),
raising the possibility that Wnt signaling and Foxo1 sig-
naling may be hierarchically related or share a common
set of target genes. More work will be required to ad-
dress these questions.
Foxo1 overexpression leads to a remarkable alter-
ation in Chop10 expression patterns during adipocyte
differentiation. However, since we have been unable to
demonstrate direct control of the Chop10 promoter by
Foxo1, it is possible that altered Chop10 expression is
solely a result of Foxo1 inhibition of cell cycle progres-
sion. Alternatively, Foxo1 could promote expression of
another protein that regulates Chop10.
Finally, analysis of mice with Foxo haploinsufficiency
is consistent with an in vivo role of Foxo1 in the process
of adipocyte differentiation. The regulation of adipocyte
differentiation by Foxo1 can potentially affect insulin
sensitivity by regulating adipocyte size. Inhibition of
Figure 7. Foxo1 Haploinsufficiency Protects against Increased Adi- (C) The number of fat cells within a random microscopic field was
pocyte Size and Changes in Adipocyte Gene Expression in Mice determined by counting cells in at least six different random fields
Fed a High-Fat Diet per mouse and six mice for each genotype and treatment group.
(A) Epididymal fat weight in wild-type (empty bars) and Foxo1
/ mice An asterisk indicates a significant difference (p  0.05 by ANOVA)
(full bars) (n  10 each), after 15 weeks of either HC or HF diet. between wild-type and Foxo1
/ mice.
(B) Adipocyte size in epididymal fat pads was determined by mor- (D) Gene expression in epididymal fat samples was determined by
phometric analyses of hematoxylin- and eosin-stained adipose tis- RT-PCR in three mice for each genotype. Each PCR was carried
sue sections. At least 500 cells were evaluated in six mice for each out in triplicate. For each gene, we report the values in control (HC)
genotype. and high-fat-fed (HF) mice.
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U24171). We cloned the amplified products into the HindIII site ofFoxo1 function holds promise as a therapeutic approach
pGL3basic vector (Promega). We confirmed the identity of theto insulin resistance and diabetes.
cloned products by DNA sequencing. The day prior to transfection,
we plated SV40-transformed hepatocytes onto 6-well plates. WeExperimental Procedures
performed transfections on 80% confluent cells using 1.5 g of
cMyc-tagged Foxo1 plasmid (wild-type, ADA, or 256) and 2 g ofmRNA Isolation, Northern Blotting, and Real-Time RT-PCR
pGL3B/p21. We used plasmid pRSV--galactosidase (20 ng) as anWe performed mRNA isolation and Northern hybridization according
internal control of transfection efficiency. After transfection, we incu-to standard techniques. We carried out real-time RT-PCR on pooled
bated cells in complete AMEM for 24 hr. Thereafter, we replacedsamples from three 2-month-old mice using a Roche LightCycler
medium with serum-free AMEM containing 0.1% bovine serum albu-PCR instrument and LightCycler SYBR Green I (Roche Perkin-Elmer)
min with or without insulin (100 nM) and incubated it for 16 hr.RNA amplification kit. Each reaction was carried out in triplicate
We performed luciferase and -galactosidase assays as describedunder standard reaction conditions. Primer sequences used to am-
previously (Nakae et al., 2001).plify Foxo1, Foxo3, Foxo4, Ppar, Glut4, Leptin, Acrp30, Tnf	, Re-
sistin, Srebp-1c, and -actin are available upon request.
Gel Shift Assays
We isolated nuclei from SV40-transformed mouse hepatocytes byCell Culture and Induction of Adipocyte Differentiation
sequential extraction in NaCl (Schreiber et al., 1989). We used two3T3-F442A preadipocytes were maintained in DMEM containing 25
oligonucleotide probes: probe A (5-gaggaatttgtttttgttttagaggca-3;mM glucose and supplemented with 10% calf serum, 2 mM L-glu-
nt –1369 to –1395 in AF457187) and probe B (5-aaaatttttgtttgtgtttgtttamine, 50 U/ml penicillin, and 50 g/ml streptomycin. Forty-eight
tcgagagag-3; nt –1337 to –1367). We incubated double-strandedhours after cells had reached confluence, we induced adipocyte
32P-labeled oligonucleotide probes (20,000 cpm, 5 fmol), corre-differentiation by adding insulin (5 g/ml) to the culture medium for
sponding to the consensus forkhead binding sites in the p21 pro-24 hr. In vitro differentiation was detected by staining cells with oil
moter, with nuclear extracts for 20 min at room temperature in thered O solution (0.5% in isopropyl alcohol solution-distilled water
presence of 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM MgCl2,60:40) for 30 min and then washing three times with distilled water.
0.5 mM EDTA, 4% glycerol, 0.5 mM DTT, and 100 ng of poly(dI-LLC cells and SV40-transformed hepatocytes were cultured as
dC). We resolved the DNA/protein complexes on 6% nondenaturingdescribed (Nakae et al., 2001).
polyacrylamide gel and visualized them by autoradiography. For
super shift experiments, we incubated anti-Foxo1 or nonimmunePreparation of EF from Insr/ Mice and Induction
sera with nuclear extracts for 10 min at room temperature. We incu-of Adipocyte Differentiation
bated competitor wild-type and mutant probes in the reaction mix-We set up intercrosses of Insr
/ mice to recover embryos at day
ture for 10 min prior to the addition of the radiolabeled probe.E13.5. We dissected embryos from the uterus and extraembryonic
membranes, minced them into small pieces, and incubated them
Chromatin Immunoprecipitation Assaysfor 30 min in 4 ml of 0.25% trypsin-EDTA solution at 37C. We
We treated cultures of 3T3-F422A cells at various stages of differen-stopped the reaction by adding DMEM supplemented with 10%
tiation with 1% formaldehyde for 10 min at room temperature andFCS, 50 U/ml penicillin, and 50 g/ml streptomycin. We resus-
rinsed them in PBS. Thereafter, we lysed cells in buffer containingpended cell aggregates by pipetting and plated them on 15 cm
1% SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.1), and proteaseculture dishes. After 2 days, we trypsinized cells, replated them on
inhibitors (Roche) and sonicated samples using a Sonic Dismembra-12-well dishes, and cultured them in the same medium. Two days
tor (Model 550; Fisher) at maximal power setting with 20, 10 s pulsesafter cells achieved confluence, we replaced the medium with
at 4C. Following centrifugation, we diluted the lysates 1:10 in bufferAMEM supplemented with 10% FCS, 50 U/ml penicillin, 50 g/ml
containing 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1),streptomycin, 0.5 mM IBMX, 1 M dexamethasone, and 5 g/ml
and 150 mM NaCl and precleared them with 40 l of salmon sperminsulin for induction of differentiation. We genotyped embryos as
DNA/protein A-Sepharose for 2 hr at 4C. After removal of the Sepha-described (Kido et al., 2000).
rose beads by centrifugation, we performed immunoprecipitation
with anti-Foxo1 antiserum or an equal amount of normal rabbit IgGTransduction of Constitutively Active
(Santa Cruz Biotechnology) for 1 hr at 4C and then precipitationand Dominant-Negative Foxo1
of the antibody-protein-DNA complexes with salmon sperm DNA/We have described adenoviral vectors encoding wild-type, constitu-
protein A-Sepharose. We washed the precipitates sequentially intively active (ADA), and dominant-negative (256) mutant Foxo1 in
buffers containing 0.1% SDS, 1% TritonX-100, 2 mm EDTA, and 20previous publications (Nakae et al., 2001). We transduced cells 2
mM TrisHCl (pH 8.1) supplemented with either 150 mM (buffer I) ordays after confluence by incubating them with adenoviral prepara-
500 mM NaCl (buffer II) prior to a final wash in 250 mM LiCl, 1%tions at different moi for 4 hr.
NP-40, 1% deoxycholate, 1 mM EDTA, and 10 mM TrisHCl (pH 8.1).
We washed the pellets with TE buffer and extracted them with 1%Western Blotting and Immunoprecipitation
SDS and 100 mM Na2HCO3. After heating at 66C for 6 hr to releaseWe homogenized tissues in buffer containing 10 mM HEPES (pH
crosslinked DNA, we digested proteins with Proteinase K and puri-7.6), 1.5 mM MgCl2, 0.5 mM DTT, 10 mM KCl, 10 mM NaF, 1 mM
fied DNA with QIAquick Spin Kit (Qiagen). We subjected the samplesNa3VO4, and 0.5 mM PMSF. After 15 min at 4C, we added NP-40
to PCR using the following primers: 5-aactcacagcttctccaaagcagg-to a final concentration of 2%. Following centrifugation (12,000 rpm
3 and 5-catgtatgaagccaggagttggat-3 (nt 1253–1276 and 1501–for 1 min at 4C), we resuspended the pellet in nuclear lysis buffer
1524 of the p21 promoter; GenBank accession number AF5457187).containing 20 mM HEPES (pH 7.5), 25% glycerol, 420 mM NaCl, 0.2
We employed standard reaction conditions and 25 cycles of amplifi-mM EDTA, 0.5 mM DTT, 10 mM NaF, 1 mM Na3VO4, 0.5 mM PMSF,
cation (Gerrish et al., 2001).1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS (Nakae
et al., 2002). After centrifugation to remove insoluble material, we
Immunofluorescenceprocessed a 50 g aliquot for electrophoresis and Western blotting
We seeded 3T3-F442A cells into 4-well slide culture chambers (Labas described, using anti-Foxo1 antibody (H128, Santa Cruz), anti-
Tek) and performed immunocytochemistry with anti-Foxo1 antibodyphosphoSer253 Foxo1 antibody (Cell Signaling), anti-HA monoclonal
at different time points during differentiation as described (Nakaeantibody (12CA5; Boehringer Mannheim), anti-p27 monoclonal anti-
et al., 2000).body (BD Transduction Laboratories), or anti-p21 monoclonal anti-
body (PharMingen).
Histological Analysis
We removed epididymal fat from 4- to 6-month-old mice, fixed thePromoter Assays
We amplified the mouse p21 promoter using primers 5-ggaagctta specimens in 10% paraformaldehyde, and embedded them in paraf-
fin. We mounted consecutive 10 m sections on slides and stainedgacttccaccccccatcaca-3 (nt 2671–2691) and 5-ggaagctttgagac
gaggcctcgctatgt-3 (nt 3381–3361; GenBank accession number them with hematoxylin and eosin. We calculated adipose cell size
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with the NIH Image 1.62 software by manual tracing of at least 500 Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W., Wright,
C., White, M., Arden, K., and Accili, D. (2002). The transcriptionadipocytes for each genotype.
factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic
-cell growth. J. Clin. Invest. 110, 1839–1847.High-Fat Diet
We have described previously the generation of Foxo1
/ mice (Na- Kohn, A.D., Summers, S.A., Birnbaum, M.J., and Roth, R.A. (1996).
kae et al., 2002). Individually caged animals were fed either normal Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1
chow or high-fat diet beginning at weaning (3 weeks) for a 15 week adipocytes stimulates glucose uptake and glucose transporter 4
period. The high-fat diet consisted of 45% of calories from fat, 35% translocation. J. Biol. Chem. 271, 31372–31378.
from carbohydrate, and 20% from protein (Research Diets). Food Kops, G.J., and Burgering, B.M. (1999). Forkhead transcription fac-
consumption did not change among the various experimental tors: new insights into protein kinase B (c-akt) signaling. J. Mol.
groups. Med. 77, 656–665.
Kops, G.J., Medema, R.H., Glassford, J., Essers, M.A., Dijkers, P.F.,
Analytical Procedures Coffer, P.J., Lam, E.W., and Burgering, B.M. (2002). Control of cell
We measured glucose and insulin levels and performed glucose cycle exit and entry by protein kinase B-regulated forkhead tran-
and insulin tolerance tests as described (Nakae et al., 2002). We scription factors. Mol. Cell. Biol. 22, 2025–2036.
performed descriptive statistics and analysis of variance (ANOVA)
Medema, R.H., Kops, G.J., Bos, J.L., and Burgering, B.M. (2000).using the Stasview software (Abacus).
AFX-like forkhead transcription factors mediate cell-cycle regulation
by Ras and PKB through p27kip1. Nature 404, 782–787.
Acknowledgments
Miki, H., Yamauchi, T., Suzuki, R., Komeda, K., Tsuchida, A., Kubota,
N., Terauchi, Y., Kamon, J., Kaburagi, Y., Matsui, J., et al. (2001).This work was supported NIH grants DK57539 and DK58282. We
Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 inthank members of the Accili laboratory for critical discussion of the
adipocyte differentiation. Mol. Cell. Biol. 21, 2521–2532.data and Prof. Kenji Fujieda (Asahikawa Medical College) for making
Morrison, R.F., and Farmer, S.R. (1999). Role of PPARgamma inhis laboratory available to complete these studies.
regulating a cascade expression of cyclin- dependent kinase inhibi-
tors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J. Biol.Received: August 7, 2002
Chem. 274, 17088–17097.Revised: November 21, 2002
Nakae, J., Barr, V., and Accili, D. (2000). Differential regulation of
gene expression by insulin and IGF-1 receptors correlates withReferences
phosphorylation of a single amino acid residue in the forkhead tran-
scription factor FKHR. EMBO J. 19, 989–996.Accili, D., and Taylor, S.I. (1991). Targeted inactivation of the insulin
receptor gene in mouse 3T3-L1 fibroblasts via homologous recombi- Nakae, J., Biggs, W.I., Kitamura, T., Cavenee, W., Wright, C., Arden,
nation. Proc. Natl. Acad. Sci. USA 88, 4708–4712. K., and Accili, D. (2002). Regulation of insulin action and pancreatic
beta-cell function by mutated alleles of the gene encoding forkheadAhima, R.S., and Flier, J.S. (2000). Adipose tissue as an endocrine
transcription factor Foxo1. Nat. Genet. 32, 245–253.organ. Trends Endocrinol. Metab. 11, 327–332.
Nakae, J., Kitamura, T., Silver, D.L., and Accili, D. (2001). The fork-Batchvarova, N., Wang, X.Z., and Ron, D. (1995). Inhibition of adipo-
head transcription factor Foxo1 (Fkhr) confers insulin sensitivity ontogenesis by the stress-induced protein CHOP (Gadd153). EMBO J.
glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359–1367.14, 4654–4661.
Rosen, E.D., Walkey, C.J., Puigserver, P., and Spiegelman, B.M.Chen, P.L., Riley, D.J., Chen, Y., and Lee, W.H. (1996). Retinoblas-
(2000). Transcriptional regulation of adipogenesis. Genes Dev. 14,toma protein positively regulates terminal adipocyte differentiation
1293–1307.through direct interaction with C/EBPs. Genes Dev. 10, 2794–2804.
Ross, S.E., Erickson, R.L., Gerin, I., DeRose, P.M., Bajnok, L., Longo,Cinti, S., Eberbach, S., Castellucci, M., and Accili, D. (1998). Lack
K.A., Misek, D.E., Kuick, R., Hanash, S.M., Atkins, K.B., et al. (2002).of insulin receptors affects the formation of white adipose tissue in
Microarray analyses during adipogenesis: understanding the effectsmice. A morphological and ultrastructural analysis. Diabetologia 41,
of Wnt signaling on adipogenesis and the roles of liver X receptor171–177.
alpha in adipocyte metabolism. Mol. Cell. Biol. 22, 5989–5999.Datta, S.R., Brunet, A., and Greenberg, M.E. (1999). Cellular survival:
Rubin, C.S., Lai, E., and Rosen, O.M. (1977). Acquisition of increaseda play in three Akts. Genes Dev. 13, 2905–2927.
hormone sensitivity during in vitro adipocyte development. J. Biol.
Fajas, L., Landsberg, R.L., Huss-Garcia, Y., Sardet, C., Lees, J.A.,
Chem. 252, 3554–3557.
and Auwerx, J. (2002). E2Fs regulate adipocyte differentiation. Dev.
Sakaue, H., Ogawa, W., Matsumoto, M., Kuroda, S., Takata, M.,Cell 3, 39–49.
Sugimoto, T., Spiegelman, B.M., and Kasuga, M. (1998). Posttran-
Gerrish, K., Cissell, M.A., and Stein, R. (2001). The role of hepatic
scriptional control of adipocyte differentiation through activation of
nuclear factor 1 alpha and PDX-1 in transcriptional regulation of the
phosphoinositide 3-kinase. J. Biol. Chem. 273, 28945–28952.
pdx-1 gene. J. Biol. Chem. 276, 47775–47784.
Schreiber, E., Matthias, P., Muller, M.M., and Schaffner, W. (1989).
Gregoire, F.M., Smas, C.M., and Sul, H.S. (1998). Understanding
Rapid detection of octamer binding proteins with ‘mini-extracts’,
adipocyte differentiation. Physiol. Rev. 78, 783–809.
prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
Hansen, J.B., Petersen, R.K., Larsen, B.M., Bartkova, J., Alsner, J., Spiegelman, B.M., and Flier, J.S. (2001). Obesity and the regulation
and Kristiansen, K. (1999). Activation of peroxisome proliferator- of energy balance. Cell 104, 531–543.
activated receptor gamma bypasses the function of the retinoblas-
Tang, Q.Q., and Lane, M.D. (2000). Role of C/EBP homologous pro-toma protein in adipocyte differentiation. J. Biol. Chem. 274, 2386–
tein (CHOP-10) in the programmed activation of CCAAT/enhancer-2393.
binding protein-beta during adipogenesis. Proc. Natl. Acad. Sci.
Hu, E., Kim, J.B., Sarraf, P., and Spiegelman, B.M. (1996). Inhibition USA 97, 12446–12450.
of adipogenesis through MAP kinase-mediated phosphorylation of
Wang, X.Z., and Ron, D. (1996). Stress-induced phosphorylation andPPARgamma. Science 274, 2100–2103.
activation of the transcription factor CHOP (GADD153) by p38 MAP
Kaestner, K.H., Knochel, W., and Martinez, D.E. (2000). Unified no- kinase. Science 272, 1347–1349.
menclature for the winged helix/forkhead transcription factors.
Wu, Z., Rosen, E.D., Brun, R., Hauser, S., Adelmant, G., Troy, A.E.,Genes Dev. 14, 142–146.
McKeon, C., Darlington, G.J., and Spiegelman, B.M. (1999). Cross-
Kido, Y., Burks, D.J., Withers, D., Bruning, J.C., Kahn, C.R., White, regulation of C/EBP alpha and PPAR gamma controls the transcrip-
M.F., and Accili, D. (2000). Tissue-specific insulin resistance in mice tional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3,
with combined mutations of insulin receptor, IRS-1 and IRS-2. J. 151–158.
Clin. Invest. 105, 199–205.
